Dublin, Oct. 17, 2017 -- The "Nanotechnology in Medical Applications: The Global Market" report has been added to Research and Markets' offering.
The Global Nanomedical Market is Projected to Grow at a CAGR of 14.0% from 2017-2022, and Should Reach $293.1
This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets.
The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity.
Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.
Report Includes
- An overview of the global markets for nanotechnology used in medical applications
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications
- Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness
- A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market
Key Topics Covered:
1: Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Scope of Report
- Market Analyses and Forecasts
- Methodology
- Intended Audience
- Information Sources
2: Summary and Highlights
- Definition
- Research and Commercialization
- Applications
- Overview
- About Nanotechnology
- Many Uses of Nanotechnology
- Nanotechnology in the Marketplace
- Nanomedicine Market
3: Nanomedicine
- Development of Nanomedical Technologies
- Therapeutic Uses of Nanomedicine
- Future Trends and Research Possibilities
- Fundamental Nanotechnology Research
4: Markets for Nanomedicine
- Market Drivers
- Market Estimates and Forecasts
- Regional and National Market Analysis
5: The Nanomedicine Industry
- Ablynx NV
- Abraxis Bioscience (Celgene)
- Aphios Corp.
- Bioforce Nanosciences Holdings Inc.
- Bio-Gateag
- Calando Pharmaceuticals Inc.
- C Sixty Inc. (Arrowhead Pharmaceuticals)
- Elan (Alkermes Corp.)
- Farfield Scientific (Biolin Scientific Ab)
- Igi Laboratories (Teligent Inc.)
- Kereos Inc.
- Keystone Nano Inc.
- Kleindiek Nanotechnikgmbh
- Labopharm (Paladin Labs)
- Liplasome Pharma Aps
- Magforce Nanotechnologies
- Magnamedics Gmbh
- Microfluidics Corp.
- MIV Therapeuticsinc.
- Molecular Profiles (Juniper Pharma Services)
- Nanobio Corp.
- Nanobiotix
- Nanocarrier Co. Ltd
- Nanocopoeia, Inc.
- Nanocyte Inc.
- Nanologix Inc.
- Nanomed Pharmaceuticalsinc.
- Nanomix Inc.
- Nanopharm Ag
- Nanospectra Biosciencesinc.
- Nanosphere Inc. (Luminex Corp.)
- Nanostructures Inc.
- Nanosyn Inc.
- Nanotherapeutics Inc.
- Nanotrope Inc.
- Nanoviricides Inc
- Nucryst Pharmaceuticals
- Nutralease
- Orthovita Inc. (Stryker Corp.)
- Pioneer Surgical Technology (Rti Surgical)
- Psivida Ltd.
- Solubest Ltd
- Starpharma
- Tecangroup Ltd.
- Transgenex Nanobiotech Inc.
6: Appendix: Glossary
For more information about this report visit https://www.researchandmarkets.com/research/9xgvzg/nanotechnology_in
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Nanotechnology, Nanomedicine


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



